Paper Details 
Original Abstract of the Article :
OBJECTIVES: The oral hypoglycemic agent chlorpropamide was evaluated for embryopathic effects in the mouse embryo model. STUDY DESIGN: Mouse embryos (n = 10 to 31 per group) were exposed in whole embryo culture to serum from chlorpropamide-treated rats or chlorpropamide-supplemented control rat ser...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/0002-9378(93)90098-4

データ提供:米国国立医学図書館(NLM)

Chlorpropamide and Embryonic Development: A Cautionary Tale in Mouse Embryos

Chlorpropamide, an oral hypoglycemic agent used to treat diabetes, has been the subject of concern regarding potential embryopathic effects. This research investigates the embryopathic effects of chlorpropamide in cultured mouse embryos. The authors exposed embryos to serum from chlorpropamide-treated rats or chlorpropamide-supplemented control rat serum, analyzing the impact on embryonic development, growth, and protein content.

A Peek into Embryonic Development: Chlorpropamide's Impact

The study reveals that chlorpropamide can have significant effects on embryonic development in vitro. At concentrations overlapping therapeutic levels in humans, chlorpropamide induced malformations, reduced embryonic protein content, and impaired growth. These findings raise concerns about the potential teratogenic effects of chlorpropamide, highlighting the need for caution in its use during pregnancy.

A Call for Vigilance: Balancing Benefits and Risks

This research underscores the importance of weighing the potential benefits and risks of medications during pregnancy. While chlorpropamide may be a valuable treatment for diabetes, the study's findings suggest that its use during pregnancy should be carefully considered. The authors emphasize the need for further research to clarify the teratogenic potential of chlorpropamide and develop safer treatment options for diabetic women during pregnancy.

Dr. Camel's Conclusion

Imagine a delicate desert flower, its fragile petals representing the developing embryo. Chlorpropamide, like a harsh desert wind, can disrupt the flower's growth and development. This research, like a careful desert botanist observing the impact of the wind, highlights the potential dangers of chlorpropamide during pregnancy. The journey to a healthy pregnancy requires a delicate balance of care and precaution, ensuring that the precious desert flower can blossom into a healthy and thriving life.

Date :
  1. Date Completed 1993-09-27
  2. Date Revised 2019-06-15
Further Info :

Pubmed ID

8362957

DOI: Digital Object Identifier

10.1016/0002-9378(93)90098-4

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.